Literature DB >> 27813514

It's a gas! Pneumatic release of VMT.

T L Jackson1, D H Steel2,3.   

Abstract

Mesh：

Year:  2016        PMID： 27813514      PMCID： PMC5350360          DOI： 10.1038/eye.2016.229

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  13 in total

1.  Intravitreal expansile gas in the treatment of early macular hole: reappraisal.

Authors:  Ta-Ching Chen; Chang-Hao Yang; Chung-May Yang
Journal:  Ophthalmologica       Date:  2012-06-08       Impact factor: 3.250

2.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

Authors:  Peter Stalmans; Matthew S Benz; Arnd Gandorfer; Anselm Kampik; Aniz Girach; Stephen Pakola; Julia A Haller
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

3.  Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction.

Authors:  Ian A Rodrigues; Alexandros N Stangos; Dominic A McHugh; Timothy L Jackson
Journal:  Am J Ophthalmol       Date:  2012-11-17       Impact factor: 5.258

4.  Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe art thou?

Authors:  Judy E Kim
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

5.  Ocriplasmin - variable efficacy?

Authors:  David H W Steel; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-04       Impact factor: 3.117

6.  Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons.

Authors:  R J Haynes; D Yorston; D A H Laidlaw; J Keller; D H W Steel
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

7.  Treatment of idiopathic macular holes by induced posterior vitreous detachment.

Authors:  C K Chan; I F Wessels; E J Friedrichsen
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

8.  Pneumatic release of focal vitreomacular traction.

Authors:  M G Claus; E Feron; M Veckeneer
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

9.  INTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME.

Authors:  Shelley Day; Jose A Martinez; Peter A Nixon; Mark Levitan; James W Dooner; Robert W Wong; Clio A Harper
Journal:  Retina       Date:  2016-04       Impact factor: 4.256

10.  Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment.

Authors:  Keisuke Mori; Sumiyo Saito; Peter L Gehlbach; Shin Yoneya
Journal:  Ophthalmology       Date:  2006-10-27       Impact factor: 12.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.